| HOME >> BIOLOGY >> TECHNOLOGY |
Reflects Full Scope of Integrated Global Services
CAMBRIDGE, Mass., April 1, 2008 /PRNewswire/ -- Abt Associates Clinical Trials today launches under a new name, Abt Bio-Pharma Solutions, Inc., a wholly owned subsidiary of Abt Associates Inc. The company will continue to provide custom strategic, research and communication solutions for the pharmaceutical, biotechnology, medical device and diagnostics industries utilizing a team approach that blends decades of experience with wide ranging technical and therapeutic area expertise.
Abt Bio-Pharma Solutions (ABS) offers a wide range of integrated services across the product lifecycle, including health economics and outcomes research, registries and other real world studies, clinical trials, biometrics and marketing consulting and research. Experienced professional staff lead cross-functional teams that are better able to address the complex issues facing the bio-pharma industry. Sponsors find that this integrated, collaborative approach promotes cost- and time-effective solutions to their business problems, with the result that the organization has grown 30 percent over the past year.
"ABS helps sponsors achieve success for their products in a very competitive marketplace," said Steven Fosburg, Executive Vice President and Managing Director of ABS. "We will leverage the increased flexibility that our new organization affords to invest in staff and resources to meet the expanding needs of our global client base without sacrificing any of the scientific rigor or timeliness that we are known for." ABS will open an office in Basel, Switzerland in May 2008.
Abt Associates has been a leader in healthcare-related research since
1965. "Abt Associates has a strong commitment to improving the health of
people and communities around the world," said Wendell J. Knox, President
and CEO of Abt Associates. "Abt Bio-Pharma Solutions is well positioned to
respond to the clinical research and
'/>"/>
| SOURCE Abt Associates Copyright©2008 PR Newswire. All rights reserved |